Roche (OTCMKTS:RHHBY) Hits New 12-Month High – Here’s What Happened
by Jessica Moore · The Cerbat GemRoche Holding AG (OTCMKTS:RHHBY – Get Free Report) shares hit a new 52-week high during trading on Wednesday . The company traded as high as $58.30 and last traded at $58.23, with a volume of 122494 shares. The stock had previously closed at $56.58.
Analyst Ratings Changes
RHHBY has been the subject of a number of recent research reports. Morgan Stanley reissued an “underweight” rating on shares of Roche in a report on Wednesday. HSBC reiterated a “buy” rating and set a $57.00 price objective on shares of Roche in a research note on Wednesday, December 10th. JPMorgan Chase & Co. upgraded shares of Roche from an “underweight” rating to a “neutral” rating in a research note on Monday, December 8th. Jefferies Financial Group cut shares of Roche from a “hold” rating to a “moderate sell” rating in a research report on Monday, October 27th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Roche from a “sell” rating to a “hold” rating in a research report on Tuesday, November 11th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $57.00.
View Our Latest Report on RHHBY
Roche Stock Up 1.0%
The business has a 50-day moving average price of $52.66 and a two-hundred day moving average price of $45.95. The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.02 and a current ratio of 1.29.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the stock. Curio Wealth LLC acquired a new position in Roche in the third quarter valued at about $25,000. Oakworth Capital Inc. bought a new stake in shares of Roche in the 3rd quarter valued at about $57,000. First Horizon Advisors Inc. raised its position in shares of Roche by 81.2% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,843 shares of the company’s stock valued at $75,000 after acquiring an additional 826 shares during the period. Salomon & Ludwin LLC boosted its stake in Roche by 256.6% during the 3rd quarter. Salomon & Ludwin LLC now owns 2,853 shares of the company’s stock worth $129,000 after acquiring an additional 2,053 shares during the last quarter. Finally, Albert D Mason Inc. acquired a new position in Roche during the fourth quarter valued at approximately $207,000.
Roche Company Profile
Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).
In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.